CMEOFCREO MED GROUP LTD.

About CREO MED GROUP LTD. (CMEOF)

CREO MED GROUP LTD. (CMEOF) is a Medical Devices company headquartered in Chepstow, WLS, United Kingdom whose shares trade over-the-counter on the Pink tier.

Creo Medical Group PLC, through its subsidiaries, researches, develops, manufactures, and sells medical devices and instruments in the United Kingdom. It is developing CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with flexible, accurate, and highly controllable devices delivered through a flexible endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for flexible endoscopy; MicroBlate Fine, a microwave needle ablation device; MicroBlate Flex, a flexible microwave ablation device designed for soft tissue ablation; SlypSeal Flex, a flexible haemostasis device for the treatment of upper and lower GI bleeds; and SpydrBlade Flex, a flexible bipolar RF and microwave scissor device that grasps, cuts and, coagulates highly perfused tissues. In addition, it provides endotherapy accessories comprising ScopeSnare, an energy-based polypectomy snares; ScopeSnare Cold, a cutting wire for use in endoscopically in the removal of diminutive, sessile and pedunculated polyps, and tissue from within the GI tract; ScopeClip, a single-use rotational and repositionable hemoclips; ScopeBite, a portfolio of biopsy forceps; ScopeGrasp, a portfolio of grasping forceps; and ScopeInject, an injection needle.

CMEOF key facts

Ticker symbol

CMEOF

Market tier

Pink

Sector

Healthcare

Industry

Medical Devices

Headquarters

Chepstow, WLS, United Kingdom

Estimated market cap

$57.91M (as of May 9, 2025)

Shares outstanding

313,004,399

Reporting standard

International Reporting: LSE - London Stock Exchange

Audit status

Audited

Fiscal year end

12/31

Explore more: Medical Devices stocks · Healthcare sector · Pink stocks · OTC stocks starting with C